Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Odyssey Outcomes Committees And Investigators

Research output: Contribution to journal › Article › Scientific › peer-review

2474 Citations (Scopus)

Original language	English
Pages (from-to)	2097-2107
Journal	The New England Journal of Medicine
Volume	379
Issue number	22
DOIs	https://doi.org/10.1056/nejmoa1801174
Publication status	Published - 2018
Publication type	A1 Journal article-refereed

Publication forum classification

@article{86bf103fc15d4782871520a6e986ad27,

title = "Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome",

author = "{Odyssey Outcomes Committees And Investigators} and GG Schwartz and PG Steg and M Szarek and S Vikman",

year = "2018",

doi = "10.1056/nejmoa1801174",

language = "English",

volume = "379",

pages = "2097--2107",

journal = "The New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "22",

}

TY - JOUR

T1 - Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

AU - Odyssey Outcomes Committees And Investigators

AU - Schwartz, GG

AU - Steg, PG

AU - Szarek, M

AU - Vikman, S

PY - 2018

Y1 - 2018

U2 - 10.1056/nejmoa1801174

DO - 10.1056/nejmoa1801174

M3 - Article

SN - 0028-4793

VL - 379

SP - 2097

EP - 2107

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

IS - 22

ER -